Business
Press Release Mar 07 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 07, 2023, titled "Zydus receives finalapproval from the USFDA for Lenalidomide Capsules, 2.5 mg and 20 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 07, 2023, titled \"Zydus receives finalapproval from the USFDA for Lenalidomide Capsules, 2.5 mg and 20 mg\". View Attachment","length":352,"tagName":"div"}]